Help
Options
Didn't know it?
click below
click below
Knew it?
click below
click below
Don't Know
Remaining cards (0)
Know
retry
shuffle
restart
0:00
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.
Normal Size Small Size show me how
Normal Size Small Size show me how
Biliary Disease
Gastroenterology
| Question | Answer |
|---|---|
| Biliary labs | bilirubin, alk phos, ALT, AST |
| Cholestatic vs hepatitis: labs | cholestasis: bili/alk phos high; hep: ALT/AST high |
| Firstline test in pt with RUQ pain, suspect cholecystitis: | US (not CT) |
| CT & MRI | X-section imaging of entire abd; eval liver parenchyma; MRI ID’s stones well; BUT: Cost; May miss stones;Radiation |
| EUS useful in: | large pt |
| 2 indications for HIDA | Cholecystitis when US is negative; leaks after cholecystectomy |
| Cholesterol stones: | GB; Large, yellow |
| Black pigment stones: | GB; Calcium bilirubinate; in pts with cirrhosis and chronic hemolysis (eg, sickle cell) |
| Brown pigment stones: | Ducts; Calcium salt of unconjugated bilirubin; assoc w/ infection; Form denovo in the ducts |
| Gold standard for GS | US; sensitivity > 95% for stones > 2mm (less sensitive for stones in CBD); GS best seen after 8hrs of fast; Stones seen as echogenic, mobile objects with acoustic shadow |
| Most common stone locations | 75% GB (Asx); cystic duct (20% intermittent: biliary colic; 10% impacted: cholecystitis) |
| Cholangitis | Stone in CBD; bile stasis, infection, bacteremia; Charcot’s triad/ Reynold’s Pentad; high WBC; Bili, ALP; pos blood cx; Emergent ERCP / PTC w/ Abx; Subsequent cholecystectomy |
| Charcot’s triad: | Pain, Fever, Jaundice |
| Reynold’s Pentad: | Charcot’s triad plus hypotension and mental confusion; suggests sepsis |
| Most effective procedure for detecting and removing cholangitis stones | ERCP; appear as filling defects; high rate of complications |
| Choledocholithiasis | Causes intermittent obstruction of CBD; indistinguishable from biliary pain; Predisposes to cholangitis and pancreatitis; |
| Choledocholithiasis: findings | Pain with jaundice; Elevated ALP, bili; ERCP / MRI / EUS / US |
| Choledocholithiasis: Tx | ERCP with stone removal and early lap cholecystectomy |
| EUS: | Highly accurate for CBD stones; invasive / expensive; No risk of pancreatitis compared to ERCP |
| Panc ca: most common sx | Pain, obstructive jaundice, weight loss; BUT classic hx = painless jaundice |
| Panc ca: RFs | smoking, chronic pancreatitis, obesity and family history; 5 year survival of 5% |
| Diffuse intra- and extrahepatic bile duct inflammation and fibrosis: | PSC |
| PSC: assoc with: | UC (most cases); leads to cirrhosis and portal HTN; elev alk phos, pruritus, fatigue; Cholangitis |
| Organisms complicating cholecystitis (found in GB or CBD: | E Coli (41%), Enterococcus (12%), Klebsiella (11%), Enterobacter (9%), B fragilis, Pseudomonas |
| Mirizzi syndrome = | a gallstone impacted in the distal cystic duct causing extrinsic compression of the common bile duct |
| Cholecystitis abx: | Augmentin (2G TID), Zosyn, Rocephin + Flagyl, OR Levaquin + Flagyl |
| Biliary disease risk factors | 4Fs, Hispanic, rapid wt loss, insulin resistance/ CHO intake, high TG, IBD |
| Biliary colic | Referred pain to R shoulder |
| Elevated Alkaline phosphatase, urinary bilirubin | Cholecystitis |
| Hx IBD, progressive RUQ pain, wt loss, F, jaundice & pruritis. Elevated bilrubin & alkaline phosphate. ERCP with bile duct stenosis, dilatation | Primary sclerosing cholangitis (diffuse intra- and extrahepatic duct sclerosing and dilatation) |
| Bacterial agents of cholecystitis/biliary disease: | Enterobacteriaceae, Enterococcus, Bacteroides Clostridium species |
| Gall stones: Etiology related to: | increasing conc of cholesterol (chol stones: 80%) or bile salts (pigments stones: 15%) |
| Primary sclerosing cholangitis (PSC) = | stricture of biliary ducts; UC>CD; risk for CRC; refer to hepatologist |
| Whipple dz: Dx | arthralgias; GI sx; wt loss, chronic cough, low-grade fever, neuro sx (steady-state: wt loss & diarrhea); bx is confirmatory (villous atrophy, macrophage infiltration of lamina propria) |
| Black pigment gall stones: | GB; Calcium bilirubinate; in pts with cirrhosis and chronic hemolysis (eg, sickle cell) |
| Brown pigment gall stones: | Ducts; Calcium salt of unconjugated bilirubin; assoc w/ infection; Form denovo in the ducts |
| Most common stone locations | 75% GB (Asx); cystic duct (20% intermittent: biliary colic; 10% impacted: cholecystitis) |
| Diffuse intra- and extrahepatic bile duct inflammation and fibrosis: | Primary sclerosing cholangitis (PSC) |
| Primary sclerosing cholangitis (PSC): assoc with: | UC (most cases); leads to cirrhosis and portal HTN; elev alk phos, pruritus, fatigue; Cholangitis |
| Action of CCK on biliary system | causes contraction of gallbladder and relaxation of sphincter of Oddi |
| Hormones affecting gallbladder motility (3): | somatostatin & estrogen (decreased GB contraction); CCK (stimulates GB contraction) |
Created by:
Abarnard
Popular Medical sets